줄기세포 증식 기술 시장 규모, 점유율 및 동향 분석 보고서 : 세포 종별, 기술별, 제품 유형별, 용도별, 최종사용자별, 지역별 및 부문별 예측(2026-2033년)

Stem Cell Expansion Technologies Market Summary

The global stem cell expansion technologies market size was estimated at USD 2.2 billion in 2025 and is projected to reach USD 4.9 billion by 2033, growing at a CAGR of 10.9% from 2026 to 2033. The market is driven by rising demand for stem cell therapies, increasing regenerative medicine research, and advancements in automated cell expansion technologies.

Global Stem Cell Expansion Technologies Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global stem cell expansion technologies market report based on technology, product, cell type, application, end-user, and region:

• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Adherent Cell Expansion Technologies
• Suspension Cell Expansion Technologies
• Automated & Closed-System Expansion Technologies
• Others
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Consumables
• Bioreactors & Expansion Systems
• Culture Media & Reagents
• Others
• Cell Type Outlook (Revenue, USD Million, 2021 - 2033)
• Mesenchymal Stem Cells (MSCs)
• Hematopoietic Stem Cells (HSCs)
• Induced Pluripotent Stem Cells (iPSCs)
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Regenerative Medicine
• Cell & Gene Therapy
• Drug Discovery & Development
• Others
• End-user Outlook (Revenue, USD Million, 2021 - 2033)
• Biotechnology & Pharmaceutical Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Technology Segment
  • 1.2.2. Product Segment
  • 1.2.3. Cell Type Segment
  • 1.2.4. Application Segment
  • 1.2.5. End User Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Stem Cell Expansion Technologies Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising adoption of stem cell therapies in regenerative medicine
    • 3.2.1.2. Technological advancements in automated and scalable expansion systems
    • 3.2.1.3. Growing investments in cell & gene therapy research
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of stem cell expansion systems and manufacturing
    • 3.2.2.2. Stringent regulatory and quality compliance requirements
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenge analysis
• 3.3. Case Study Insights
• 3.4. Stem Cell Expansion Technologies Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
  • 3.4.2. PESTEL Analysis

Chapter 4. Stem Cell Expansion Technologies Market: Technology Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Stem Cell Expansion Technologies Market Technology Movement Analysis
• 4.3. Global Stem Cell Expansion Technologies Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 4.4. Adherent cell expansion technologies
  • 4.4.1. Adherent cell expansion technologies market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Suspension cell expansion technologies
  • 4.5.1. Suspension cell expansion technologies market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. Automated & closed system expansion technologies
  • 4.6.1. Automated & closed-system expansion technologies market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.7. Others
  • 4.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Stem Cell Expansion Technologies Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Stem Cell Expansion Technologies Market Product Movement Analysis
• 5.3. Global Stem Cell Expansion Technologies Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 5.4. Consumables
  • 5.4.1. Consumables market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Bioreactors & Expansion Systems
  • 5.5.1. Bioreactors & expansion systems market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Culture Media & Reagents
  • 5.6.1. Culture media & reagents market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Stem Cell Expansion Technologies Market: Cell Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Stem Cell Expansion Technologies Market Cell Type Movement Analysis
• 6.3. Global Stem Cell Expansion Technologies Market Size & Trend Analysis, by Cell Type, 2021 to 2033 (USD Million)
• 6.4. Mesenchymal Stem Cells (MSCs)
  • 6.4.1. Mesenchymal Stem Cells (MSCs) market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Hematopoietic Stem Cells (HSCs)
  • 6.5.1. Hematopoietic Stem Cells (HSCs) market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Induced Pluripotent Stem Cells (iPSCs)
  • 6.6.1. Induced Pluripotent Stem Cells (iPSCs) market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Stem Cell Expansion Technologies Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Stem Cell Expansion Technologies Market Application Movement Analysis
• 7.3. Global Stem Cell Expansion Technologies Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 7.4. Regenerative medicine
  • 7.4.1. Regenerative medicine market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Cell & gene therapy
  • 7.5.1. Cell & gene therapy market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Drug discovery & development
  • 7.6.1. Drug discovery & development market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Stem Cell Expansion Technologies Market: End User Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Stem Cell Expansion Technologies Market End User Movement Analysis
• 8.3. Global Stem Cell Expansion Technologies Market Size & Trend Analysis, by End User, 2021 to 2033 (USD Million)
• 8.4. Biotechnology & pharmaceutical companies
  • 8.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Academic & research institutes
  • 8.5.1. Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.6. Contract Research Organizations (CROs)
  • 8.6.1. Contract Research Organizations (CROs) market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.7. Others
  • 8.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Stem Cell Expansion Technologies Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2025 & 2033
• 9.2. Regional Market Dashboard
• 9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 9.4. North America
  • 9.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.5. Europe
  • 9.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. Norway
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Competitive scenario
    • 9.5.7.3. Regulatory framework
    • 9.5.7.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.8. Sweden
    • 9.5.8.1. Key country dynamics
    • 9.5.8.2. Competitive scenario
    • 9.5.8.3. Regulatory framework
    • 9.5.8.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.9. Denmark
    • 9.5.9.1. Key country dynamics
    • 9.5.9.2. Competitive scenario
    • 9.5.9.3. Regulatory framework
    • 9.5.9.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Competitive scenario
    • 9.6.3.3. Regulatory framework
    • 9.6.3.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Competitive scenario
    • 9.6.4.3. Regulatory framework
    • 9.6.4.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.5. Australia
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Competitive scenario
    • 9.6.5.3. Regulatory framework
    • 9.6.5.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.6. South Korea
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Competitive scenario
    • 9.6.6.3. Regulatory framework
    • 9.6.6.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Competitive scenario
    • 9.6.7.3. Regulatory framework
    • 9.6.7.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.7. Latin America
  • 9.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. Argentina
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.8. MEA
  • 9.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Competitive scenario
    • 9.8.2.3. Regulatory framework
    • 9.8.2.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key country dynamics
    • 9.8.3.2. Competitive scenario
    • 9.8.3.3. Regulatory framework
    • 9.8.3.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key country dynamics
    • 9.8.4.2. Competitive scenario
    • 9.8.4.3. Regulatory framework
    • 9.8.4.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key country dynamics
    • 9.8.5.2. Competitive scenario
    • 9.8.5.3. Regulatory framework
    • 9.8.5.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2025
• 10.4. Company Profiles/Listing
  • 10.4.1. Thermo Fisher Scientific
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. Merck KGaA
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Sartorius AG
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Corning Incorporated
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. Miltenyi Biotec
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Takara Bio Inc.
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Terumo BCT
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. STEMCELL Technologies
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Lonza Group
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. Danaher Corporation
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives